BIO-key announces 1-for-10 reverse stock split to regain Nasdaq compliance

BIO KEY INTERNATIONAL INC

Reverse stock split ratio set at 1-for-10, effective 5:00 p.m. ET on April 29, 2026; trading begins split-adjusted April 30, 2026.
Outstanding shares reduced from ~10,852,118 to ~1,085,212; no fractional shares, rounding up to nearest whole share.
Stockholders approved the split at an April 20, 2026 special meeting; Board chose the ratio to meet Nasdaq minimum bid price requirement.
CEO Michael DePasquale stated the split intends to position the stock for bid price compliance while pursuing growth and profitability.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BIO KEY INTERNATIONAL INC: Certificate of Amendment filed to effect a 1-for-10 reverse stock split of common stock, approved by stockholders on April 20, 2026 and filed on April 28, 2026 (effective 2026-04-29).

Change: charter amendment
Effective: 2026-04-29

Exact text from the filing

the Company filed a Certificate of Amendment (the “ Certificate of Amendment ”) with the Secretary of State of the State of Delaware to effect the reverse stock split. The Certificate of Amendment will become effective at 5:00 p.m., Eastern Time, on April 29, 2026.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

BIO KEY INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001437749-26-013905

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.